BPC-157 is not FDA-approved for any medical condition
On his podcast, Andrew Huberman, MD, professor of neurobiology and ophthalmology at Stanford Universitys school of medicine, shared a potential, and slightly gory, origin story for BPC-157
BPC 157 ameliorates pulmonary hypertension
Regular treatment over a certain duration can lead to noticeable improvement in skin tone and texture
Initial analysis of our RNA-seq dataset comparing melatonin- and vehicle-treated ILC2s revealed broad suppression of pro-inflammatory gene expression following melatonin treatment, including canonical type 2 cytokines such as Il5 , Il13 , and Csf2
Learn More Featured Education A simpler path to BCGP recertification Whether youre planning ahead or preparing for your next recertification cycle, APhA offers flexible ways to earn BCGP credits while strengthening your expertise in the care of older adults